F.D.A. Panel Votes Against Expansion of Anticoagulant
The Food and Drug Administration said concerns over bleeding outweighed the evidence that Xarelto reduced the risk of blood clots. (Source: NYT Health)

Readers' letters - 24 May 2012
Trusts slow to sign up to an important public health deal (Source: HSJ)